We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00064714
First Posted: July 11, 2003
Last Update Posted: March 11, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
AstraZeneca
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: August 13, 2010
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):